Wyniki wyszukiwania

1

Antichlamydial antibodies in the serum and expressed prostatic secretion in prostatitis

100%

Ostaszewska-Puchalska I., Zdrodowska-Stefanow B., Badyda J., Bulhak-Koziol V., Pucilo K., Darewicz B.

Archivum Immunologiae et Therapiae Experimentalis

|

2004

|

tom 52

|

nr 4

2

First report of a case of prostatitis due to Acanthamoeba in a dog

72%

Lorenzo-Morales J., Valladares M., Sancho J., Reyesbatlle M., Martin-Navarro M., Lopez-Arencibia A., Gonzalez A. C., Lopez-Medina L., Pinero J. E., Martinez-Carretero E., Valladares B.

Acta Protozoologica

|

2013

|

tom 52

|

nr 4

3

The effect of Chlamydia trachomatis infection of the prostate gland on the concentration of citric acid

72%

Zdrodowska-Stefanow B., Ostaszewska-Puchalska I., Badyda J., Galewska Z.

Archivum Immunologiae et Therapiae Experimentalis

|

2006

|

tom 54

|

nr 1

4

Antichlamydial antibodies and citric acid in patients with chronic prostatitis

72%

Ostaszewska-Puchalska I., Zdrodowska-Stefanow B., Badyda J., Galewska Z.

Archivum Immunologiae et Therapiae Experimentalis

|

2007

|

tom 55

|

nr 1

5

Artykuł dostępny w postaci pełnego tekstu - kliknij by otworzyć plik

Fosfomycin as an alternative therapeutic option for treatment of infections caused by multi-resistant Gram-negative bacteria

58%

Zdzieblo M., Andrzejczuk S., Chudzik-Rzad B., Juda M., Malm A.

Journal of Pre-Clinical and Clinical Research

|

2014

|

tom 08

|

nr 2

The problem of significantly reduced drug use concerns particularly the infections caused by multi-resistant pathogens, especially Gram-negative bacteria. In this regard, interest is increasing in the known for nearly 50 years, but now frequently forgotten antibiotic – fosfomycin. Fosfomycin possesses high effectiveness for multidrug-resistant bacteria, comprising of extended-spectrum β-lactamases (ESBL), Klebsiella pneumoniae carbapenemases (KPC); commonly, the pandrug-resistant (PDR) and the extensively drug-resistant (XDR) strains, especially from Enterobacteriaceae family. Because of facilitated distribution into inflamed tissues and a very broad range of in vitro bactericidal activity, fosfomycin may have various applications in the treatment of many kinds of bacterial infections, including acute uncomplicated infections of the urinary bladder or complicated urinary tract infections, urinary tract sepsis, pyelonephritis, cystitis, prostatitis and chronic lung infections in patients with cystic fibrosis, the great majority caused by multi-resistant Gram-negative bacteria, and in the therapy eradicating multidrug-resistant Helicobacter pylori. Fosfomycin may limit the toxicity of other antibiotics and play a protective role in the process of bacterial resistance development during the therapy. Combinations of different antimicrobials enable the use of forgotten antibiotics in commonly occurring infections, although they are still completely incurable.

Ograniczanie wyników

3 Archivum Immunologiae et Therapiae Experimentalis

1 Acta Protozoologica

1 Journal of Pre-Clinical and Clinical Research

3 Badyda J.

3 Ostaszewska-Puchalska I.

3 Zdrodowska-Stefanow B.

2 Galewska Z.

1 Andrzejczuk S.

1 Bulhak-Koziol V.

1 Chudzik-Rzad B.

1 Darewicz B.

1 Gonzalez A. C.

1 Juda M.

1 Lopez-Arencibia A.

1 Lopez-Medina L.

1 Lorenzo-Morales J.

1 Malm A.

1 Martin-Navarro M.

1 Martinez-Carretero E.

1 Pinero J. E.

1 Pucilo K.

1 Reyesbatlle M.

1 Sancho J.

1 Valladares B.

1 Valladares M.

1 Zdzieblo M.

1 2014

1 2013

1 2007

1 2006

1 2004

Antichlamydial antibodies in the serum and expressed prostatic secretion in prostatitis

First report of a case of prostatitis due to Acanthamoeba in a dog

The effect of Chlamydia trachomatis infection of the prostate gland on the concentration of citric acid

Antichlamydial antibodies and citric acid in patients with chronic prostatitis

Fosfomycin as an alternative therapeutic option for treatment of infections caused by multi-resistant Gram-negative bacteria